Immune Landscape of Pancreatic Cancer Development and Drug Resistance

Immune Landscape of Pancreatic Cancer Development and Drug Resistance
Author :
Publisher : Elsevier
Total Pages : 284
Release :
ISBN-10 : 9780443235221
ISBN-13 : 0443235228
Rating : 4/5 (228 Downloads)

Book Synopsis Immune Landscape of Pancreatic Cancer Development and Drug Resistance by : Batoul Farran

Download or read book Immune Landscape of Pancreatic Cancer Development and Drug Resistance written by Batoul Farran and published by Elsevier. This book was released on 2024-06-07 with total page 284 pages. Available in PDF, EPUB and Kindle. Book excerpt: Immune landscape of pancreatic cancer development and drug resistance explores the advances in immune-based therapies aimed at harnessing the power of the immune system against pancreatic cancer and rewiring tumor microenvironments to eradicate pancreatic cells. With a strong focus on the development of therapeutic methods to improve the survival rates of pancreatic cancer, this book also shows the latest trends in immune targeted approaches for pancreatic cancer treatment. In 12 chapters Immune landscape of pancreatic cancer development and drug resistance discusses the current understanding of PC development and its various mutational and immune features and explore some of the new immune-based therapies aimed at targeting pancreatic cancer. It covers the urgent need for developing novel therapeutic modalities and aims at delineating future fields and avenues of research in pancreatic cancer treatment. The book provides the reader with an updated understanding of the immune landscape of PC and an all-encompassing overview of the latest trends in immune targeted approaches for PC treatment. This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of the advances in immunotherapy in pancreatic cancer. - Summarizes the potential combination strategies and latest clinical trials in pancreatic cancer - Provides an in-depth overview of our current understanding of pancreatic cancer development, including its mutational and immune features - Explores some of the new immune-based therapies aimed at targeting PC - Shows pancreatic cancer progression and basic elements in tumor microenvironments and their role in PC progression, also covering immunotherapy strategies


Immune Landscape of Pancreatic Cancer Development and Drug Resistance Related Books

Immune Landscape of Pancreatic Cancer Development and Drug Resistance
Language: en
Pages: 284
Authors: Batoul Farran
Categories: Science
Type: BOOK - Published: 2024-06-07 - Publisher: Elsevier

GET EBOOK

Immune landscape of pancreatic cancer development and drug resistance explores the advances in immune-based therapies aimed at harnessing the power of the immun
Theranostic Approach for Pancreatic Cancer
Language: en
Pages: 420
Authors: Ganji Purnachandra Nagaraju
Categories:
Type: BOOK - Published: 2020-01-15 - Publisher: Academic Press

GET EBOOK

Theranostic Approach for Pancreatic Cancer modulates the biologic properties of stroma in pancreatic cancer by targeting the several chemotherapy resistance mec
Hyaluronan in Cancer Biology
Language: en
Pages: 467
Authors: Robert Stern
Categories: Medical
Type: BOOK - Published: 2009-03-07 - Publisher: Academic Press

GET EBOOK

Hyaluronan biology is being recognized as an important regulator of cancer progression. Paradoxically, both hyaluronan (HA) and hyaluronidases, the enzymes that
Cancer Drug Resistance
Language: en
Pages: 611
Authors: Beverly A. Teicher
Categories: Medical
Type: BOOK - Published: 2007-11-09 - Publisher: Springer Science & Business Media

GET EBOOK

Leading experts summarize and synthesize the latest discoveries concerning the changes that occur in tumor cells as they develop resistance to anticancer drugs,
Immune Checkpoint Inhibitors in Cancer
Language: en
Pages: 271
Authors: Fumito Ito
Categories: Medical
Type: BOOK - Published: 2018-09-03 - Publisher: Elsevier Health Sciences

GET EBOOK

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of can